Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Analytical Community Rewards Postnova System with 2012 Innovations Award

Published: Monday, December 17, 2012
Last Updated: Monday, December 17, 2012
Bookmark and Share
The new CF2000 Series for high-resolution separation and fractionation of nanoparticles has won the prestigious GIT Innovations Award 2012 in the category ‘Analytical Instrumentation and Software’.

The Postnova team are the inventors of the Field-Flow Fractionation (FFF) technique, and developed the CF2000 to be the first Centrifugal FFF system for routine use.

Dr Thorsten Klein, Founder and CEO, Postnova, said: “It is a great honour to receive this award. To be acknowledged by scientists working at the bench is particularly important for us as it shows that our innovative products are recognized as powerful practical tools for daily analysis, exactly what we designed them to be. I would like to thank the publishers at G.I.T. Verlag for sponsoring the award, the independent jury who placed the CF2000 on the shortlist and, most of all, everyone who took the time to vote for us online, at Analytica, and at Achema.”

The CF2000 is modular, allowing for a range of different detectors: Multi-Angle Light Scattering (MALS) , Dynamic Light Scattering (DLS) and Refractive Index (RI), for example, to be integrated. Whatever the configuration, everything from autosampler to detector is fully controlled by the NovaFFF software platform.
 
Importantly, by using a centrifugal field as the controlling force for the separation, particles are separated by Dynamic Diffusion on the basis of size and density. This novel approach allows discrimination of materials that have the same particle size but different densities.

The CF2000 has a wide operation range and is able to separate smaller species, such as proteins and polymers, from larger particles in one run with high resolution. The system is ideal for nanoparticles and works up into the microparticle size range too. No special sample treatment is necessary, allowing challenging biopharmaceutical, food-cosmetics, nanomaterial and environmental samples to be characterized.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Postnova Analytics Opens UK Office
Company has announced that it has opened a dedicated office to enhance local support for its growing base of UK customers.
Wednesday, March 16, 2016
Scientific News
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
More Effective Strategy for Producing Flu Vaccines
Researchers have developed a virus backbone, allowing producers to grow vaccine viruses in mammalian cells, rather than in eggs.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Vaccination Against UTIs
Researchers have successfully vaccinated mice against E.coli growth in the bladder and kidneys.
First Steps to Neutralising Zika
Researchers have discovered a highly potent antibody that neutralises Zika infection at a cellular level.
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Fighting Off HIV Infection Closer to Reality
Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.
Powerful New Tools to Combat Zika
Researchers have created a way to replicate the stucture of Zika virus, removing the genes that make the virus infectious.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!